Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Slavneft-Yaroslavnefteorgsintez reported for 3 months of 2024 by RAS

4/24/24 JNOS

Saratov Oil Refinery reported for 3 months of 2024 by RAS

4/24/24 KRKN

Board of Directors of Ryazanenergosbyt recommended dividends

4/24/24 RZSB

TGC-1's generation in Q1 increased by 7%

4/24/24 TGKA

Krasny Oktyabr reported for 3 months of 2024 by RAS

4/24/24 KROT

Fesco reported for 2023 by IFRS

4/24/24 FESH

Board of Directors of UralSib Bank recommended that dividends be paid for 2023

4/24/24 USBN

Astra wants to capture up to half of the software development systems market

4/24/24 ASTR

UGC reported for 2023 by IFRS

4/24/24 UGLD

Ozon launched delivery of goods within 30 minutes

4/24/24 OZON